Novo Nordisk stops two cardiovascular studies aimed at lowering inflammation
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Novo Nordisk has stopped two trials of a drug that aims to tame inflammation as a way to improve cardiovascular health, another blow for the approach. The company said it had halted the … [Read more…]